MRIN

The MRIN is founded with the aim to conduct innovative research in cancer, to understand the association of gene mutation or changes with cancer development in Indonesian patients. By using genomic and proteomic approach, we currently study the association of hepatitis B and C viruses genotype and mutation with liver cancer development; the immune response of certain biomarkers for developing innovative immunotherapy intervention strategies for the treatment of cancer. We use candidate gene approach and SNP microarray to identify novel cancer susceptibility loci and to evaluate genetic variations in relation with drug response, so to obtain evidence-based data for cancer prevention and early diagnosis... Equipped with advanced laboratory and animal facility, MRIN-ACRO offers in-vitro and in-vivo service platforms that can be tailored to clients' need. The barrier animal facility will allow for acquisition and maintenance of SPF rodent models, which are pre-requisite for assurance of..

Primary location: Lippo Karawaci Indonesia